|
1
|
Kasai T, Chen L, Mizutani A, Kudoh T,
Murakami H, Fu L and Seno M: Cancer stem cells converted from
pluripotent stem cells and the cancerous niche. J Stem Cells Regen
Med. 10:2–7. 2014.PubMed/NCBI
|
|
2
|
Visvader JE and Stingl J: Mammary stem
cells and the differentiation hierarchy: Current status and
perspectives. Genes Dev. 28:1143–1158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geng SQ, Alexandrou AT and Li JJ: Breast
cancer stem cells: Multiple capacities in tumor metastasis. Cancer
Lett. 349:1–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fu N, Lindeman GJ and Visvader JE: The
mammary stem cell hierarchy. Curr Top Dev Biol. 107:133–160. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Steinestel K, Eder S, Schrader AJ and
Steinestel J: Clinical significance of epithelial-mesenchymal
transition. Clin Transl Med. 3:172014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hao J, Zhang Y, Deng M, Ye R, Zhao S, Wang
Y, Li J and Zhao Z: MicroRNA control of epithelial-mesenchymal
transition in cancer stem cells. Int J Cancer. 135:1019–1027. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vislovukh A, Vargas TR, Polesskaya A and
Groisman I: Role of 3′-untranslated region translational control in
cancer development, diagnostics and treatment. World J Biol Chem.
5:40–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Rooij E and Kauppinen S: Development
of microRNA therapeutics is coming of age. EMBO Mol Med. 6:851–864.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan X, Chen X, Liang H, Deng T, Chen W,
Zhang S, Liu M, Gao X, Liu Y, Zhao C, et al: MiR-143 and miR-145
synergistically regulate ERBB3 to suppress cell proliferation and
invasion in breast cancer. Mol Cancer. 13:2202014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ng EK, Li R, Shin VY, Siu JM, Ma ES and
Kwong A: MicroRNA-143 is downregulated in breast cancer and
regulates DNA methyltransferases 3A in breast cancer cells. Tumour
Biol. 35:2591–2598. 2014. View Article : Google Scholar
|
|
13
|
Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH,
Liang S, Li B, Li Y, Li D, Wang ED and Liu MF: A novel
miR-155/miR-143 cascade controls glycolysis by regulating
hexokinase 2 in breast cancer cells. EMBO J. 31:1985–1998. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu X, Zhang X, Dhakal IB, Beggs M,
Kadlubar S and Luo D: Induction of cell proliferation and survival
genes by estradiol-repressed microRNAs in breast cancer cells. BMC
Cancer. 12:292012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia H, Sun S, Wang B, Wang T, Liang C, Li
G, Huang C, Qi D and Chu X: MiR-143 inhibits NSCLC cell growth and
metastasis by targeting Limk1. Int J Mol Sci. 15:11973–11983. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li R, Zhang L, Jia L, Duan Y, Li Y, Wang
J, Bao L and Sha N: MicroRNA-143 targets Syndecan-1 to repress cell
growth in melanoma. PLoS One. 9:e948552014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu XL, Cheng B, Li PY, Huang HJ, Zhao Q,
Dan ZL, Tian DA and Zhang P: MicroRNA-143 suppresses gastric cancer
cell growth and induces apoptosis by targeting COX-2. World J
Gastroenterol. 19:7758–7765. 2013. View Article : Google Scholar
|
|
18
|
Zhang N, Su Y and Xu L: Targeting PKCε by
miR-143 regulates cell apoptosis in lung cancer. FEBS Lett.
587:3661–3667. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Wang Z, Chen M, Peng L, Wang X,
Ma Q, Ma F and Jiang B: MicroRNA-143 targets MACC1 to inhibit cell
invasion and migration in colorectal cancer. Mol Cancer. 11:232012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z,
Li P, Zhang W, Wu H, Feng N, et al: MiR-143 decreases prostate
cancer cells proliferation and migration and enhances their
sensitivity to docetaxel through suppression of KRAS. Mol Cell
Biochem. 350:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
